Literature DB >> 24665027

[Sperm collection for medically assisted procreation in azoospermic patients].

Massimiliano Timpano1, Dario Fontana, Luigi Rolle, Mirko Preto, Marco Falcone, Mattia Sibona, Bruno Frea.   

Abstract

Infertility is defined as the inability of a sexually active non-contracepting couple to achieve spontaneous pregnancy in one year.
 Factors of male infertility are present in 50% of infertile couples.
 Azoospermia is defined as the absence of sperm in the ejaculate, even after centrifugation of the sample, and affects 10%-15% of the infertile male population. Therefore, it represents a pathological condition of primary importance in the context of infertility management.
 Any assisted reproductive procedure must first refer to the availability of a suitable number of good quality gametes.
 As regards sperm collection, if ejaculated semen is not suitable or available, it may be taken from the seminal duct or directly from the testicular parenchyma with different methodologies and techniques, which can be divided into percutaneous techniques and open surgical (TeSE and ESA) or micro-surgical (micro-TeSE) techniques.
 The purpose of this work is to evaluate and compare the retrieval rate in infertile patients suffering from azoospermia and treated with the various surgical techniques.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24665027     DOI: 10.5301/RU.2014.11984

Source DB:  PubMed          Journal:  Urologia        ISSN: 0391-5603


  2 in total

1.  Comparison of Sperm Parameters in Patients with Infertility Induced by Genital Infection versus Varicocele.

Authors:  Bogdan Pajovic; Antonio Dimitrovski; Nemanja Radojevic; Marko Vukovic
Journal:  Balkan Med J       Date:  2015-07-01       Impact factor: 2.021

2.  A novel micro-straw for cryopreservation of small number of human spermatozoon.

Authors:  Feng Liu; Sha-Sha Zou; Yong Zhu; Can Sun; Yu-Fei Liu; Shan-Shan Wang; Wen-Bo Shi; Jing-Jing Zhu; Yong-Hua Huang; Zheng Li
Journal:  Asian J Androl       Date:  2017 May-Jun       Impact factor: 3.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.